Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer

ClinicalTrials.gov ID: NCT01266447

Public ClinicalTrials.gov record NCT01266447. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 1:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Evaluation of ABT-888 (NCI Supplied Agent: ABT-888, NSC #737664), Topotecan (NSC # 609699) and Filgrastim or Pegfilgrastim in the Treatment of Persistent or Recurrent Squamous or Non-squamous Cell Carcinoma of the Cervix

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This phase II clinical trial is studying the how well veliparib, topotecan hydrochloride, and filgrastim or pegfilgrastim work in treating patients with persistent or recurrent cervical cancer. Veliparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as topotecan hydrochloride, work in different ways to stop the growth of tumor cells, either by killing the cells or by blocking them from dividing. Giving veliparib with chemotherapy may kill more tumor cells. Filgrastim or pegfilgrastim may cause the body to make more blood cells and help it recover from the side effects of chemotherapy.

Study identification

NCT ID
NCT01266447
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
27 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2011 (Type not available)
Primary completion
Jan 2016 (Actual)
Completion
Jan 2016 (Actual)
Last update posted
Aug 8, 2019

2011 – 2016

United States locations

U.S. sites
78
U.S. states
25
U.S. cities
59
Facility City State ZIP Site status
UC Irvine Health/Chao Family Comprehensive Cancer Center Orange California 92868 —
University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora Colorado 80045 —
Smilow Cancer Hospital Care Center at Saint Francis Hartford Connecticut 06105 —
The Hospital of Central Connecticut New Britain Connecticut 06050 —
Florida Hospital Orlando Orlando Florida 32803 —
Memorial University Medical Center Savannah Georgia 31404 —
Saint Alphonsus Cancer Care Center-Boise Boise Idaho 83706 —
Decatur Memorial Hospital Decatur Illinois 62526 —
Sudarshan K Sharma MD Limted-Gynecologic Oncology Hinsdale Illinois 60521 —
Memorial Medical Center Springfield Illinois 62781 —
Indiana University/Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 —
University of Iowa/Holden Comprehensive Cancer Center Iowa City Iowa 52242 —
Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore Maryland 21287 —
Saint Joseph Mercy Hospital Ann Arbor Michigan 48106-0995 —
Michigan Cancer Research Consortium CCOP Ann Arbor Michigan 48106 —
Oakwood Hospital and Medical Center Dearborn Michigan 48124 —
Saint John Hospital and Medical Center Detroit Michigan 48236 —
Hurley Medical Center Flint Michigan 48502 —
Genesys Regional Medical Center Grand Blanc Michigan 48439 —
Allegiance Health Jackson Michigan 49201 —
Borgess Medical Center Kalamazoo Michigan 49001 —
Bronson Methodist Hospital Kalamazoo Michigan 49007 —
West Michigan Cancer Center Kalamazoo Michigan 49007 —
Sparrow Hospital Lansing Michigan 48912 —
Saint Mary Mercy Hospital Livonia Michigan 48154 —
Saint Joseph Mercy Oakland Pontiac Michigan 48341 —
Saint Joseph Mercy Port Huron Port Huron Michigan 48060 —
Saint Mary's of Michigan Saginaw Michigan 48601 —
University of Mississippi Medical Center Jackson Mississippi 39216 —
Cancer Research for the Ozarks NCORP Springfield Missouri 65804 —
Mercy Hospital Springfield Springfield Missouri 65804 —
CoxHealth South Hospital Springfield Missouri 65807 —
Women's Cancer Center of Nevada Las Vegas Nevada 89169 —
Cooper Hospital University Medical Center Camden New Jersey 08103 —
Southwest Gynecologic Oncology Associates Inc Albuquerque New Mexico 87106 —
University of New Mexico Cancer Center Albuquerque New Mexico 87106 —
State University of New York Downstate Medical Center Brooklyn New York 11203 —
North Shore University Hospital Manhasset New York 11030 —
Long Island Jewish Medical Center New Hyde Park New York 11040 —
North Shore-LIJ Health System/Center for Advanced Medicine New Hyde Park New York 11040 —
Case Western Reserve University Cleveland Ohio 44106 —
Riverside Methodist Hospital Columbus Ohio 43214 —
Lake University Ireland Cancer Center Mentor Ohio 44060 —
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 —
Oklahoma Cancer Specialists and Research Institute-Tulsa Tulsa Oklahoma 74146 —
Abington Memorial Hospital Abington Pennsylvania 19001 —
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 —
Women and Infants Hospital Providence Rhode Island 02905 —
University Medical Center Brackenridge Austin Texas 78701 —
Parkland Memorial Hospital Dallas Texas 75235 —
Zale Lipshy University Hospital Dallas Texas 75235 —
Clements University Hospital Dallas Texas 75390 —
UT Southwestern/Simmons Cancer Center-Dallas Dallas Texas 75390 —
Scott and White Memorial Hospital Temple Texas 76508 —
Virginia Commonwealth University/Massey Cancer Center Richmond Virginia 23298 —
PeaceHealth Medical Group PC Bellingham Washington 98226 —
Harrison HealthPartners Hematology and Oncology-Bremerton Bremerton Washington 98310 —
Harrison Medical Center Bremerton Washington 98310 —
Providence Regional Cancer Partnership Everett Washington 98201 —
Skagit Valley Hospital Regional Cancer Care Center Mount Vernon Washington 98273 —
Harrison HealthPartners Hematology and Oncology-Poulsbo Poulsbo Washington 98370 —
Pacific Gynecology Specialists Seattle Washington 98104 —
Fred Hutchinson Cancer Research Center Seattle Washington 98109 —
Seattle Cancer Care Alliance Seattle Washington 98109 —
Group Health Cooperative-Seattle Seattle Washington 98112 —
Swedish Medical Center-First Hill Seattle Washington 98122-4307 —
Northwest Hospital Seattle Washington 98133 —
University of Washington Medical Center Seattle Washington 98195 —
Olympic Medical Cancer Care Center Sequim Washington 98384 —
Cancer Care Northwest - Spokane South Spokane Washington 99202 —
Rockwood Cancer Treatment Center-DHEC-Downtown Spokane Washington 99204 —
MultiCare Tacoma General Hospital Tacoma Washington 98405 —
Saint Joseph Medical Center Tacoma Washington 98405 —
Providence Saint Mary Regional Cancer Center Walla Walla Washington 99362 —
Wenatchee Valley Hospital and Clinics Wenatchee Washington 98801 —
D N Greenwald Center Mukwonago Wisconsin 53149 —
Oconomowoc Memorial Hospital-ProHealth Care Inc Oconomowoc Wisconsin 53066 —
Waukesha Memorial Hospital Waukesha Wisconsin 53188 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01266447, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 8, 2019 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01266447 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →